RD Lewis Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.22M Buy
3,236
+30
+0.9% +$35.4K 3.16% 8
2026
Q2
$3.89M Buy
3,206
+285
+10% +$291K 2.88% 9
2026
Q1
$2.79M Sell
2,921
-30
-1% -$30.4K 2.42% 13
2025
Q4
$2.96M Buy
2,951
+79
+3% +$75.5K 2.53% 13
2025
Q3
$2.92M Buy
2,872
+211
+8% +$157K 2.74% 11
2025
Q2
$1.71M Sell
2,661
-5
-0.2% -$3.88K 1.72% 24
2025
Q1
$2.2M Buy
2,666
+121
+5% +$101K 2.49% 11
2024
Q4
$2.24M Buy
+2,545
New +$2.11M 2.46% 12

Other funds holding LLY

RD Lewis Holdings's LLY Position: Q3 2026 in Review

RD Lewis Holdings increased its Eli Lilly (LLY) stake by 0.94% in Q3 2026, buying an estimated $35.4K and bringing the position to 3,236 shares worth $4.22M. The position accounts for 3.16% of the portfolio, ranked #8.

RD Lewis Holdings first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • RD Lewis Holdings held 3,236 shares of Eli Lilly worth $4.22M as of Q3 2026.
  • RD Lewis Holdings bought 30 Eli Lilly shares in Q3 2026, an estimated $35.4K.
  • Eli Lilly made up 3.16% of RD Lewis Holdings's portfolio in Q3 2026, its #8 holding.
  • RD Lewis Holdings first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on RD Lewis Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.